Preview Mode Links will not work in preview mode

Evidence Based Medicine presented by InpharmD™

  1. All Episodes
  2. Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Sep 26, 2020

What does the evidence say on the safety and immunogenicity of the new Novavax vaccine for the SARS-CoV-2 infection?